Strong Buy on WVE-N531 and WVE-006 catalysts, Phase data, and cash runway into 2028. Click for this WVE stock update.
This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...
Gilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.
Pharmaceutical Technology on MSN
Gilead Sciences completes Tubulis acquisition for $5bn
Gilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.
Whether space, health, technology or environment, here are the issues in science that the editors of Scientific American are focusing on for 2026 A trove of e-mails from convicted sex offender Jeffrey ...
WASHINGTON — The National Academies of Sciences, Engineering, and Medicine’s New Voices in Sciences, Engineering, and Medicine program has announced its 2026-2028 cohort of members, a group of 20 ...
Nursing Clinical Professor Darci McCall is the first person from the College of Health Sciences to be named a Provost's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results